Issue Code: PHA
2,137
481
290
2025--2026
LMH STRATEGIC SOLUTIONS
72 activities
MARSHALL & POPP, LLC
62 activities
MEHLMAN CONSULTING, INC.
55 activities
B HALL STRATEGIES, LLC
HOUSE OF REPRESENTATIVES
1,724 mentionsSENATE
1,706 mentionsHealth & Human Services, Dept of (HHS)
477 mentionsCenters For Medicare and Medicaid Services (CMS)
NEW ENGLAND RESEARCH GROUP
via NEW ENGLAND RESEARCH GROUP
Drug access, reimbursement, patient advocacy
MANAGED HEALTH CARE ASSOCIATES, INC.
via HEALTHSPERIEN
Network adequacy; long-term care pharmacy services; Medicare access
SINGULARITY TECH PHARMA CORP (SINTEC)
52 activities
TODD STRATEGY GROUP
49 activities
RUBICON ADVISORS, LLC
44 activities
BALLARD PARTNERS
40 activities
DLA PIPER LLP (US)
39 activities
BGR GOVERNMENT AFFAIRS
35 activities
KOUNTOUPES DENHAM CARR & REID, LLC
33 activities
Food & Drug Administration (FDA)
232 mentionsWhite House Office
177 mentionsExecutive Office of the President (EOP)
128 mentionsOffice of Management & Budget (OMB)
45 mentionsHealth Resources & Services Administration (HRSA)
44 mentionsDrug Enforcement Administration (DEA)
33 mentionsvia TSG ADVOCATES DC, LLC
Provide support and advocacy related to healthcare programs and issues
CHRISTIANACARE
via CHRISTIANACARE
Issues related to the 340B Drug Discount Program
WALMART
via STATESMEN CAPITOL STRATEGIES LLC
Veterans, US Manufacturing, Organized Retail Crime, Interchange Fees, Tax, Trade, Tariffs.
STOKES PHARMACY
via POLITICAL CAPITAL, LLC
Outsourcing Facility Access and Guidance
WELBEHEALTH
via WELBEHEALTH
Senior healthcare issues.
GALDERMA LABORATORIES, L.P.
via DLA PIPER LLP (US)
Policies and proposals impacting pharmaceutical development, approval, manufacturing, and reimbursement. Trade policies and agreements, including IP protections, and administrative tariff actions.
DIABETES PATIENT ADVOCACY COALITION
via BABBAGE COFOUNDER
Access to safe and affordable insulin, all other issues relating to diabetes
TRAVERE THERAPEUTICS
via THE HEALTH EQUITY STRATEGIES GROUP, LLC
Rare kidney disease